Cost-Utility Analysis of Secukinumab use Versus Tnf-Α Inhibitors, in Patients with Ankylosing Spondilytis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2980
https://www.valueinhealthjournal.com/article/S1098-3015(17)33314-4/fulltext
Title :
Cost-Utility Analysis of Secukinumab use Versus Tnf-Α Inhibitors, in Patients with Ankylosing Spondilytis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33314-4&doi=10.1016/j.jval.2017.08.2980
First page :
A938
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2722